Biogen (BIIB) PT Lowered to $221 at Mizuho
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $199.71 --0%
Rating Summary:
26 Buy, 17 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 16
Rating Summary:
26 Buy, 17 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 16
Join SI Premium – FREE
Mizuho analyst Salim Syed lowered the price target on Biogen (NASDAQ: BIIB) to $221.00 (from $236.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Deutsche Bank Downgrades L'Oreal SA (OR:FP) (LRLCY) to Sell
- Xcel Energy (XEL) PT Lowered to $91 at Mizuho
- Evercore ISI Downgrades Inspire Medical Systems (INSP) to In Line
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
